Anemia profiles in patients with lung cancer : What have we learned from the european cancer anaemia survey (ECAS)?KOSMIDIS, Paris; KRZAKOWSKI, Maciej.Lung cancer. 2005, Vol 50, Num 3, pp 401-412, issn 0169-5002, 12 p.Article

Cancer clinical trials in Central and Eastern Europe: historical reviewJASSEM, Jacek; SCHOKET, Zsofia; KRZAKOWSKI, Maciej et al.Critical reviews in oncology/hematology. 2002, Vol 42, Num 2, pp 157-161, issn 1040-8428Article

Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: External validation in a phase III trial comparing vinflunine with docetaxelDI MAIO, Massimo; KRZAKOWSKI, Maciej; FOUGERAY, Ronan et al.Lung cancer. 2012, Vol 77, Num 1, pp 116-120, issn 0169-5002, 5 p.Article

New agents within the preoperative chemotherapy of non-small cell lung cancerKRZAKOWSKI, Maciej.Lung cancer. 2001, Vol 34, pp S159-S163, issn 0169-5002, SUP2Conference Paper

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: Results of a randomized, multicenter, phase III trialNABHOLTZ, Jean-Marc; FALKSON, Carla; VOROBIOF, Daniel et al.Journal of clinical oncology. 2003, Vol 21, Num 6, pp 968-975, issn 0732-183X, 8 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung CancerLANGER, Corey J; NOVELLO, Silvia; KEUNCHIL PARK et al.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2059-2066, issn 0732-183X, 8 p.Article

The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer PatientsWOJAS-KRAWCZYK, Kamila; KRAWCZYK, Paweł; MLAK, Radosław et al.Respiration (Basel). 2011, Vol 82, Num 4, pp 341-350, issn 0025-7931, 10 p.Article

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trialPIRKER, Robert; PEREIRA, Jose R; ROH, Jae-Kyung et al.Lancet (British edition). 2009, Vol 373, Num 9674, pp 1525-1531, issn 0140-6736, 7 p.Article

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyCIULEANU, Tudor; BRODOWICZ, Thomas; CUCEVIC, Branka et al.Lancet (British edition). 2009, Vol 374, Num 9699, pp 1432-1440, issn 0140-6736, 9 p.Article

Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancerRAMLAU, Rodryg; GERVAIS, Radj; SHEPHERD, Frances A et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2800-2807, issn 0732-183X, 8 p.Article

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer : A phase III trialBRODOWICZ, Thomas; KRZAKOWSKI, Maciej; JASSEM, Jacek et al.Lung cancer. 2006, Vol 52, Num 2, pp 155-163, issn 0169-5002, 9 p.Article

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, placebo-controlled trialROSEN, Lee S; GORDON, David; REITSMA, Dirk et al.Cancer. 2004, Vol 100, Num 12, pp 2613-2621, issn 0008-543X, 9 p.Article

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsLUDWIG, Heinz; VAN BELLE, Simon; SCHNEIDER, Maurice et al.European journal of cancer (1990). 2004, Vol 40, Num 15, pp 2293-2306, issn 0959-8049, 14 p.Article

A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of lifeJASSEM, Jacek; KRZAKOWSKI, Maciej; ROSZKOWSKI, Kazimierz et al.Lung cancer. 2002, Vol 35, Num 1, pp 73-79, issn 0169-5002Article

A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerRECK, Martin; KRZAKOWSKI, Maciej; CHMIELOWSKA, Ewa et al.Lung cancer. 2013, Vol 82, Num 3, pp 441-448, issn 0169-5002, 8 p.Article

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan―Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; BLACKHALL, Fiona; LETRENT, Stephen P et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3337-3344, issn 0732-183X, 8 p.Article

Independent risk factors for anemia in cancer patients receiving chemotherapy : Results from the european cancer anaemia surveyBARRETT-LEE, Peter J; LUDWIG, Heinz; SCHRIJVERS, Dirk et al.Oncology. 2006, Vol 70, Num 1, pp 34-48, issn 0030-2414, 15 p.Article

Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapyMARKOWICZ, Sergiusz; WALEWSKI, Jan; ZAJDA, Katarzyna et al.Cytokines, cellular & molecular therapy. 2002, Vol 7, Num 1, pp 15-24, issn 1368-4736Article

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the national Cancer Institute of Canada-Clinical Trials Group and the european Organization for Research and Treatment of CancerSHEPHERD, Frances A; GIACCONE, Giuseppe; KRZAKOWSKI, Maciej et al.Journal of clinical oncology. 2002, Vol 20, Num 22, pp 4434-4439, issn 0732-183X, 6 p.Article

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerSPIGEL, David R; ERVIN, Thomas J; GOVINDAN, Ramaswamy et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4105-4114, issn 0732-183X, 10 p.Conference Paper